Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Entera Bio Ltd (ENTX)
NASDAQ:ENTX
Entera Bio (ENTX) Stock Price & Analysis
310 Followers
ENTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.47 - $3.00
Previous Close$1.03
Volume62.35K
Average Volume (3M)239.80K
Market Cap
$29.67M
Enterprise Value$15.48M
Total Cash (Recent Filing)$14.32M
Total Debt (Recent Filing)$132.00K
Price to Earnings (P/E)-5.8
Beta0.75
Next Earnings
Mar 30, 2023EPS Estimate
-$0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.18
Shares Outstanding18,234,191
10 Day Avg. Volume56,720
30 Day Avg. Volume239,799
Standard Deviation0.28
R-Squared0.12
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)2.07
Price to Sales (P/S)156.51
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-2.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue54.33
Enterprise Value/Gross Profit78.20
Enterprise Value/Ebitda-1.10
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Entera Bio News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ENTX FAQ
What was Entera Bio Ltd’s price range in the past 12 months?
Entera Bio Ltd lowest stock price was $0.47 and its highest was $3.00 in the past 12 months.
What is Entera Bio Ltd’s market cap?
Currently, no data Available
When is Entera Bio Ltd’s upcoming earnings report date?
Entera Bio Ltd’s upcoming earnings report date is Mar 30, 2023 which is in 3 days.
How were Entera Bio Ltd’s earnings last quarter?
Entera Bio Ltd released its earnings results on Nov 10, 2022. The company reported -$0.11 earnings per share for the quarter, beating the consensus estimate of -$0.135 by $0.025.
Is Entera Bio Ltd overvalued?
According to Wall Street analysts Entera Bio Ltd’s price is currently Overvalued.
Does Entera Bio Ltd pay dividends?
Entera Bio Ltd does not currently pay dividends.
What is Entera Bio Ltd’s EPS estimate?
Entera Bio Ltd’s EPS estimate is -$0.12.
How many shares outstanding does Entera Bio Ltd have?
Entera Bio Ltd has 28,809,921 shares outstanding.
What happened to Entera Bio Ltd’s price movement after its last earnings report?
Entera Bio Ltd reported an EPS of -$0.11 in its last earnings report, beating expectations of -$0.135. Following the earnings report the stock price went down -19.355%.
Which hedge fund is a major shareholder of Entera Bio Ltd?
Among the largest hedge funds holding Entera Bio Ltd’s share is RA Capital Management. It holds Entera Bio Ltd’s shares valued at 216K.
---
Entera Bio Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 1.8M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 0.9%
Last 30 Days ▲ 8.9%
Last 30 Days ▲ 8.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-64.48%
12-Months-Change
Fundamentals
Return on Equity
-25.41%
Trailing 12-Months
Asset Growth
-46.63%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Entera Bio Ltd
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of orally delivered large molecule therapeutics. It develops an oral formulation of parathyroid hormone. The company was founded on June 1, 2010 and is headquartered in Jerusalem, Israel.
---
---